This is an archive article published on April 30, 2024

In a first, AstraZeneca admits its Covid vaccine Covishield can cause rare side effects

The pharmaceutical company is being sued in a class action over claims that its vaccine against Covid-19, developed with the University of Oxford, caused death and serious injury, including TTS

Covishield, Covishield vaccine, covid, covid vaccine side effects, astrazeneca, astrazeneca vaccine side effects, oxford vaccine side effects, void vaccine deaths, covid-19, astrazeneca news indian expressFifty-one cases have been lodged in the High Court, with victims and grieving relatives seeking damages estimated to be worth up to £100 million. (AP Photo/File)
4 min readNew DelhiMay 1, 2024 09:12 AM IST First published on: Apr 30, 2024 at 08:10 AM IST

AstraZeneca, for the first time, admitted in its court documents that its Covid vaccine can cause rare side effects, paving way for a multi-million pound legal payout, The Telegraph reported on Sunday.

The pharmaceutical company is being sued in a class action over claims that its vaccine against Covid-19, developed with the University of Oxford, caused death and serious injury, including TTS — Thrombosis with Thrombocytopenia Syndrome — which causes people to have blood clots and a low blood platelet count.

Advertisement

AstraZeneca, in collaboration with The University of Oxford, had developed AZD1222 vaccine after the outbreak of the coronavirus in 2020. In India and other low-and-middle-income countries, it was manufactured and supplied under the name “Covishield” by Serum Institute of India (SII) through a licence from the university and the Swedish-British drugmaker.

Latest Comment
Post Comment
Read Comments